Effects of nucleoside analogs on purine nucleotide metabolism.
D000225:Adenine / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D006147:Guanine / Q000378:metabolism; D007042:Hypoxanthines / Q000378:metabolism; D007168:IMP Dehydrogenase / Q000037:antagonists & inhibitors; D051379:Mice; D009705:Nucleosides / Q000494:pharmacology*; D010754:Phosphoribosyl Pyrophosphate / Q000096:biosynthesis; D011685:Purine Nucleotides / Q000378:metabolism*; D012265:Ribonucleotides / Q000096:biosynthesis; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D007042:Hypoxanthines; D009705:Nucleosides; D011685:Purine Nucleotides; D012265:Ribonucleotides; D006147:Guanine; D010754:Phosphoribosyl Pyrophosphate; D007168:IMP Dehydrogenase; D000225:Adenine